BD
has published data from a new study that underlines the need for safer drug
delivery practices in healthcare systems.
The
company commissioned a US-based survey showing that preventable adverse drug
events associated with injectable medications negatively impact more than one
million inpatients each year.
This
results in costs of $2.7 to $5.1 billion (1.68 to 3.17 billion pounds) in
annual costs to US healthcare payers each year, or an average of $600,000 for
every hospital.
According
to the report, the types of medications and illnesses most associated with
these harmful errors are already known, meaning measures can be taken to combat
this trend.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources